Voloridge Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History
Voloridge Investment Management, LLC
- $26.2 Billion
- Q3 2024
A detailed history of Voloridge Investment Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 137,461 shares of SUPN stock, worth $4.98 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
137,461
Previous 172,266
20.2%
Holding current value
$4.98 Million
Previous $4.61 Million
6.99%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding SUPN
# of Institutions
282Shares Held
60.9MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$376 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$222 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$185 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$104 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$95.3 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.94B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...